KovaDx is bridging the health disparity faced by people with sickle cell disease, as well as, other hemolytic anemias.
Millions of people suffer from Sickle Cell Disease and other hemolytic anemias. KovaDx is making healthcare accessible to these individuals by providing an affordable and easy to use point-of-care solution. Our system is based on Quantitative Phase Imaging and uses deep learning to make predictions.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 10, 2021 | Grant | $256K | 1 | National Science Foundation | — | Detail |
Oct 1, 2020 | Pre-seed | $100K | 1 | EXPERT DOJO | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |
EXPERT DOJO | Yes | Pre-seed |